Biotech Series A Investors & VC Firms
1596 firms in this list, with a median first check of $500K. 341 of them lead rounds. Generated from verified public data and updated continuously.
ACORN BIOVENTURES
New YorkSeed–Late Stage
4 people
Cobro Ventures
McleanSeed–Series A
4 people
Cape Fear BioCapital
DurhamPre-Seed–Series B
3 people
Day One Capital
BudapestPre-Seed–Series A$330K – $2.2M
Earlymarket
Pre-Seed–Series A
Elevat3 Capital
VallettaSeed–Growth$5M – $20M
Innventure
Pre-Seed–Growth
Octalfa
LyonPre-Seed–Late Stage$100K – $2.7M
SEEDS Capital
SingaporePre-Seed–Series B$250K – $9M
Chiesi Ventures
BostonSeed–Series A$5M
2 people
Leafy Tunnel
LondonSeed–Series A
2 people
NCL Technology Ventures Ltd.
LondonSeed–Series A
2 people
Strattech Partners, LLC
WayneSeed–Growth
2 people
Waterpoint Lane
MiamiSeed–Late Stage
2 people
Bluebird Ventures
Palo AltoSeed–Series B
1 person
First Venture
StockholmSeed–Growth
4 people
Silverleaf Venture Partners, LLC
Fort MyersSeries A–Late Stage
3 people
Trinity Innovation Bioventure Singapore
SingaporeSeed–Late Stage
3 people
WRF Capital
SeattlePre-Seed–Series B$100K – $2M
19 people
Israel Biotech Fund
RehovotSeed–Series A
5 people
Redesign Health
New YorkSeed–Late Stage
2 people
City Hill Ventures
San DiegoSeed–Series A$100K – $20M
1 person
Fir Capital
Nova LimaSeed–Growth$100K – $5M
1 person
HealthCare Ventures, LLC
CambridgeSeries A–Late Stage$1M – $20M
1 person
Related lists
Series A Investors & VC Firms (7875)Series A Investors & VC Firms in United States (3337)SaaS Series A Investors & VC Firms (2667)AI & Machine Learning Series A Investors & VC Firms (2343)Enterprise Software Series A Investors & VC Firms (2324)Fintech Series A Investors & VC Firms (2239)Healthtech Series A Investors & VC Firms (2210)Series A Investors & VC Firms in Global (2163)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)
Data sourced from public filings and firms' own websites — see our methodology.


















